Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuroscience ; 285: 292-302, 2015 Jan 29.
Artigo em Inglês | MEDLINE | ID: mdl-25451279

RESUMO

Pathophysiological conditions such as cerebral ischemia trigger the production of new neurons from the neurogenic niche within the subgranular zone (SGZ) of the dentate gyrus. The functional significance of ischemia-induced neurogenesis is believed to be the regeneration of lost cells, thus contributing to post-ischemia recovery. However, the cell signaling mechanisms by which this process is regulated are still under investigation. Here, we investigated the role of mitogen and stress-activated protein kinases (MSK1/2) in the regulation of progenitor cell proliferation and neurogenesis after cerebral ischemia. Using the endothelin-1 model of ischemia, wild-type (WT) and MSK1(-/-)/MSK2(-/-) (MSK dKO) mice were injected with BrdU and sacrificed 2 days, 4 weeks, or 6 weeks later for the analysis of progenitor cell proliferation, neurogenesis, and neuronal morphology, respectively. We report a decrease in SGZ progenitor cell proliferation in MSK dKO mice compared to WT mice. Moreover, MSK dKO mice exhibited reduced neurogenesis and a delayed maturation of ischemia-induced newborn neurons. Further, structural analysis of neuronal arborization revealed reduced branching complexity in MSK dKO compared to WT mice. Taken together, this dataset suggests that MSK1/2 plays a significant role in the regulation of ischemia-induced progenitor cell proliferation and neurogenesis. Ultimately, revealing the cell signaling mechanisms that promote neuronal recovery will lead to novel pharmacological approaches for the treatment of neurodegenerative diseases such as cerebral ischemia.


Assuntos
Isquemia Encefálica/enzimologia , Giro Denteado/enzimologia , Células-Tronco Neurais/enzimologia , Neurogênese/fisiologia , Proteínas Quinases S6 Ribossômicas 90-kDa/metabolismo , Animais , Isquemia Encefálica/patologia , Giro Denteado/patologia , Modelos Animais de Doenças , Endotelina-1 , Feminino , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , Células-Tronco Neurais/patologia , Neurônios/enzimologia , Neurônios/patologia , Proteínas Quinases S6 Ribossômicas 90-kDa/genética , Nicho de Células-Tronco/fisiologia
2.
J Pharmacol Exp Ther ; 293(2): 480-6, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10773018

RESUMO

In central neurons, glutamate receptor activation causes massive calcium influx and induces a mitochondrial depolarization, which is partially blocked by cyclosporin A, suggesting a possible activation of the mitochondrial permeability transition pore (PTP) as a mechanism. It has been recently reported that tamoxifen (an antiestrogen chemotherapeutic agent) blocks the PTP in isolated liver mitochondria, similar to cyclosporin A. In this study, we tested whether tamoxifen inhibits the mitochondrial depolarization induced by glutamate receptor activation in intact cultured neurons loaded with the fluorescent dye 5,5',6,6'-tetrachloro-1,1',3, 3'-tetraethylbenzimidazolylcarbocyanine iodide. This dye reports disruptions in mitochondrial membrane potential, which can be caused by PTP activation. We found that glutamate (100 microM for 10 min) causes a robust mitochondrial depolarization that is partially inhibited by tamoxifen. The maximum inhibitory concentration of tamoxifen was 0.3 microM, with concentrations higher and lower than 0.3 microM being less effective. However, although tamoxifen (0.3 microM) blocked glutamate-induced mitochondrial depolarization, it did not inhibit glutamate-induced neuronal death, in contrast to the PTP inhibitor cyclosporin A. A relatively high concentration of tamoxifen (100 microM) caused mitochondrial depolarization itself and was neurotoxic. These data suggest that tamoxifen may be an inhibitor of the PTP in intact neurons. However, the lack of specificity of most PTP inhibitors, and the difficulty in measuring PTP in intact cells, preclude definite conclusions about the role of PTP in excitotoxic injury.


Assuntos
Antineoplásicos Hormonais/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Ácido Glutâmico/farmacologia , Mitocôndrias/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Tamoxifeno/farmacologia , Animais , Antineoplásicos Hormonais/toxicidade , Benzimidazóis , Carbocianinas , Morte Celular/efeitos dos fármacos , Células Cultivadas , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Antagonistas de Aminoácidos Excitatórios/toxicidade , Corantes Fluorescentes , Histocitoquímica , Masculino , Malonatos/toxicidade , Potenciais da Membrana/efeitos dos fármacos , Membranas/efeitos dos fármacos , Neostriado/citologia , Neostriado/efeitos dos fármacos , Neurônios/ultraestrutura , Permeabilidade/efeitos dos fármacos , Prosencéfalo/citologia , Prosencéfalo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Tamoxifeno/toxicidade
4.
J Neurochem ; 71(3): 1051-8, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9721729

RESUMO

Increasing extracellular pH from 7.4 to 8.5 caused a dramatic increase in the time required to recover from a glutamate (3 microM, for 15 s)-induced increase in intracellular Ca2+ concentration ([Ca2+]i) in indo-1-loaded cultured cortical neurons. Recovery time in pH 7.4 HEPES-buffered saline solution (HBSS) was 126 +/- 30 s, whereas recovery time was 216 +/- 19 s when the pH was increased to 8.5. Removal of extracellular Ca2+ did not inhibit the prolongation of recovery caused by increasing pH. Extracellular alkalinization caused rapid intracellular alkalinization following glutamate exposure, suggesting that pH 8.5 HBSS may delay Ca2+ recovery by affecting intraneuronal Ca2+ buffering mechanisms, rather than an exclusively extracellular effect. The effect of pH 8.5 HBSS on Ca2+ recovery was similar to the effect of the mitochondrial uncoupler carbonyl cyanide p-(trifluoromethoxyphenyl)hydrazone (FCCP; 750 nM). However, pH 8.5 HBSS did not have a quantitative effect on mitochondrial membrane potential comparable to that of FCCP in neurons loaded with a potential-sensitive fluorescent indicator, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine++ + iodide (JC-1). We found that the effect of pH 8.5 HBSS on Ca2+ recovery was completely inhibited by the mitochondrial Na+/Ca2+ exchange inhibitor CGP-37157 (25 microM). This suggests that increased mitochondrial Ca2+ efflux via the mitochondrial Na+/Ca2+ exchanger is responsible for the prolongation of [Ca2+]i recovery caused by alkaline pH following glutamate exposure.


Assuntos
Álcalis/farmacologia , Cálcio/metabolismo , Ácido Glutâmico/farmacologia , Mitocôndrias/metabolismo , Prosencéfalo/metabolismo , Trocador de Sódio e Cálcio/metabolismo , Animais , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/farmacologia , Células Cultivadas , Clonazepam/análogos & derivados , Clonazepam/farmacologia , Concentração de Íons de Hidrogênio , Membranas Intracelulares/metabolismo , Neurônios/metabolismo , Concentração Osmolar , Prosencéfalo/citologia , Prosencéfalo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Trocador de Sódio e Cálcio/antagonistas & inibidores , Tiazepinas/farmacologia , Desacopladores/farmacologia
5.
J Physiol ; 509 ( Pt 1): 103-16, 1998 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-9547385

RESUMO

1. We have examined the mechanisms by which cultured central neurones from embryonic rat brain buffer intracellular Ca2+ loads following kainate receptor activation using fluorescent indicators of [Ca2+]i and [Na+]i. 2. Stimulation of cultured forebrain neurones with 100 microM kainate produced a rapid increase in [Ca2+]i that displayed a variable rate of recovery. Kainate also increased [Na+]i with a response that was slightly slower in onset and markedly slower in recovery. 3. The recovery of [Ca2+]i to baseline was not very sensitive to the [Na+]i. The magnitude of the increase in [Na+]i in response to kainate did not correlate well with the [Ca2+]i recovery time, and experimental manipulations that altered [Na+]i did not have a large impact on the rate of recovery of [Ca2+]i. 4. The recovery of [Ca2+]i to baseline was accelerated by the mitochondrial Na+-Ca2+ exchange inhibitor CGP-37157, suggesting that the recovery rate is influenced by release of Ca2+ from a mitochondrial pool and also that variation in the recovery rate is related to the extent of mitochondrial Ca2+ loading. Kainate did not alter the mitochondrial membrane potential. 5. These studies reveal that mitochondria have a central role in buffering neuronal [Ca2+]i changes mediated by non-N-methyl-D-aspartate (NMDA) glutamate receptors, and that the variation in recovery times following kainate receptor activation reflects a variable degree of mitochondrial Ca2+ loading. However, unlike NMDA receptor-mediated Ca2+ loads, kainate receptor activation has minimal effects on mitochondrial function.


Assuntos
Cálcio/metabolismo , Agonistas de Aminoácidos Excitatórios/farmacologia , Ácido Caínico/farmacologia , Mitocôndrias/fisiologia , Neurônios/metabolismo , Prosencéfalo/metabolismo , Sódio/fisiologia , Animais , Células Cultivadas , Clonazepam/análogos & derivados , Clonazepam/farmacologia , Corantes Fluorescentes , Potenciais da Membrana/fisiologia , Neurônios/efeitos dos fármacos , Prosencéfalo/citologia , Prosencéfalo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Receptores de N-Metil-D-Aspartato/metabolismo , Trocador de Sódio e Cálcio/antagonistas & inibidores , Estimulação Química , Tiazepinas/farmacologia
6.
Mol Pharmacol ; 53(4): 742-9, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9547366

RESUMO

Activation of ionotropic glutamate receptors causes increases in intracellular Ca2+ concentration ([Ca2+]i) and intracellular Na+ concentration in neurons. It has been suggested that reversal of the plasma membrane Na+/Ca2+ exchanger (NCE) may account in part for the rise in [Ca2+]i. Recently, KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea methanesulfonate) was reported to selectively inhibit the reverse mode of the NCE in non-neuronal cells. We investigated the effects of KB-R7943 on glutamate-stimulated increases in [Ca2+]i. In cultured rat forebrain neurons loaded with indo-1 acetoxymethyl ester, KB-R7943 inhibited the reverse mode of NCE (IC50 = 0.7 microM). When tested against kainate- (100 microM), N-methyl-D-aspartate- (30 microM), glutamate- (3 microM), or KCl- (50 mM) induced [Ca2+]i transients (15 sec, in the presence of Na+ and Ca2+), KB-R7943 inhibited these transients with IC50 values of 6. 6, 8.2, 5.2, and 2.9 microM, respectively. [Ca2+]i increases caused by a higher concentration of glutamate (100 microM) also were inhibited by KB-R7943 (10 microM). However, KB-R7943 had no effect on peak [Ca2+]i changes caused by prolonged application of glutamate and did not inhibit glutamate-induced neuronal injury. KB-R7943 did not inhibit N-methyl-D-aspartate- or kainate-induced whole-cell currents, nor did it substantially inhibit voltage-sensitive Ca2+ currents, excluding a direct inhibition of these ion channels. These results suggest that reverse NCE contributes to the immediate rise in [Ca2+]i resulting from glutamate receptor activation. However, reverse NCE becomes less important as the stimulus time is increased, and Ca2+ entry by this route is not critical for the expression of excitotoxic injury.


Assuntos
Cálcio/metabolismo , Ácido Glutâmico/farmacologia , Líquido Intracelular/metabolismo , Neurônios/metabolismo , Prosencéfalo/metabolismo , Trocador de Sódio e Cálcio/metabolismo , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Antagonistas de Aminoácidos Excitatórios/farmacologia , Ácido Caínico/farmacologia , N-Metilaspartato/farmacologia , Neurônios/efeitos dos fármacos , Prosencéfalo/citologia , Ratos , Ratos Sprague-Dawley , Receptores de Glutamato/efeitos dos fármacos , Receptores de Glutamato/metabolismo , Trocador de Sódio e Cálcio/antagonistas & inibidores , Tioureia/análogos & derivados , Tioureia/farmacologia
7.
Neurochem Res ; 22(3): 333-40, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9051670

RESUMO

We investigated the ability of hydrogen peroxide (H2O2) to cause apoptotic cell death in cultured rat forebrain neurons and the potential mechanisms by which oxidative stress triggers delayed neuronal death. H2O2 (25 microM for 5 min) reduced cell viability to 34.5 +/- 8.3% of untreated controls 20 h after exposure, and resulted in a significant proportion of neurons which exhibited apoptotic nuclear morphology. Using single cell fluorescence assays, we measured H2O2-induced changes in DNA strand breaks, 2'7' dichlorofluorescin fluorescence, reduced glutathione, intracellular free Ca2+, and mitochondrial membrane potential. DNA strand breaks in response to H2O2 were not evident immediately following exposure, but were increased 12h and 20h after exposure. Millimolar concentrations of H2O2 caused increases in the fluorescence of the oxidant-sensitive fluorescent dye, 2'7'-dichlorofluorescin. H2O2 treatment decreased reduced glutathione following 30 minutes of exposure using the fluorescent indicator, 5-chloromethylfluorescein diacetate, and increased intraneuronal free Ca2+ levels in a subpopulation of neurons. Mitochondrial membrane potential, measured by rhodamine 123 localization was unaffected by 25 microM H2O2, while higher concentrations of H2O2 (10 or 30 mM) depolarized mitochondria. These studies demonstrate that H2O2 is a potent and effective neurotoxin that produces oxidative stress, as well as apoptotic neuronal death.


Assuntos
Apoptose/efeitos dos fármacos , Peróxido de Hidrogênio/toxicidade , Neurônios/efeitos dos fármacos , Neurotoxinas/toxicidade , Estresse Oxidativo/efeitos dos fármacos , Prosencéfalo/efeitos dos fármacos , Animais , Cálcio/metabolismo , Células Cultivadas , DNA/efeitos dos fármacos , Fluoresceínas/farmacologia , Glutationa/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Oxirredução , Prosencéfalo/citologia , Ratos , Ratos Sprague-Dawley
8.
Exp Neurol ; 143(2): 269-81, 1997 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9056389

RESUMO

Injury to the brain, whether by ischemia or trauma, results in the uncontrolled release of many neurotransmitters, including glutamate and dopamine. Both of these neurotransmitters are neurotoxic in high concentrations, and the oxidative stress caused by reactive oxygen species generation has been implicated in the mechanism of neurotoxicity. In this study, we used cultured rat forebrain neurons to characterize cell death caused by exposure to dopamine and/or glutamate and to investigate potential acute mechanisms of toxicity. Dopamine exposure (250 microM for 2 h) reduced cell viability to 34. 3 +/- 5.5% of untreated control 20 h later and increased the number of neurons with apoptotic morphology. The antioxidant N-acetylcysteine (100 microM) inhibited dopamine-induced toxicity and prevented the covalent binding of dopamine quinones to protein. In contrast, glutamate toxicity lacked the hallmark characteristics of apoptosis. When neurons were exposed successively to sublethal concentrations of dopamine and glutamate, cell viability at 20 h was reduced to 62.3 +/- 5.2% of untreated control. Apoptosis was not evident, and N-acetylcysteine blocked the potentiating effect of dopamine on glutamate-induced toxicity. We used single-cell fluorescence assays to measure changes in intraneuronal glutathione, intraneuronal Ca2+, mitochondrial membrane potential, and DNA integrity as potential acute inducers of neuronal injury. While changes in these parameters could be demonstrated, none were identified as the sole acute inducer of cell death caused by dopamine. In summary, we have characterized a number of neuronal responses to lethal dopamine injury. Also, we have demonstrated that dopamine and glutamate can interact in vitro to potentiate cell death and that the potentiation appears to be induced by oxidative stress.


Assuntos
Morte Celular/efeitos dos fármacos , Dopamina/farmacologia , Ácido Glutâmico/farmacologia , Prosencéfalo/efeitos dos fármacos , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Ratos , Ratos Sprague-Dawley
9.
Br J Pharmacol ; 122(5): 803-8, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9384493

RESUMO

1. Glutamate receptor activation has been previously shown to result in mitochondrial depolarization and activation of the mitochondrial permeability transition pore in cultured neurones. In this study, we characterized the effects of two putative permeability transition inhibitors, namely trifluoperazine and dibucaine, on mitochondrial depolarization in rat intact, cultured forebrain neurones. 2. Permeability transition was monitored by following mitochondrial depolarization in neurones loaded with the mitochondrial membrane potential-sensitive fluorescent indicator, JC-1. Trifluoperazine (10 20 microM) and dibucaine (50-100 microM) inhibited or delayed the onset of glutamate-induced permeability transition. 3. We also investigated the effects of trifluoperazine and dibucaine on neuronal recovery from glutamate-induced Ca2+ loads. Trifluoperazine affected Ca2+ recovery in a manner similar to the mitochondrial Na+/Ca2+ exchange inhibitor, CGP-37157, while dibucaine had no apparent effect on Ca2+ recovery. Therefore, inhibition of permeability transition does not appear to be involved in Ca2+ recovery from glutamate-induced Ca2+ loads. 4. Trifluoperazine and dibucaine did not inhibit [3H]-dizocilpine binding at the concentrations that prevented mitochondrial depolarization. 5. These studies suggest that trifluoperazine and dibucaine inhibit permeability transition in intact neurones. Trifluoperazine also appears to inhibit mitochondrial Na+/Ca2+ exchange. These drugs should prove to be valuable tools in the further study of the role of mitochondrial permeability transition in glutamate-induced neuronal death.


Assuntos
Dibucaína/farmacologia , Ácido Glutâmico/fisiologia , Mitocôndrias/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Prosencéfalo/efeitos dos fármacos , Trifluoperazina/farmacologia , Animais , Benzimidazóis , Cálcio/metabolismo , Carbocianinas , Células Cultivadas , Clonazepam/análogos & derivados , Clonazepam/farmacologia , Dibucaína/metabolismo , Maleato de Dizocilpina/metabolismo , Corantes Fluorescentes , Fluorometria , Potenciais da Membrana/efeitos dos fármacos , Mitocôndrias/fisiologia , Neurônios/citologia , Prosencéfalo/citologia , Prosencéfalo/metabolismo , Ratos , Ratos Sprague-Dawley , Trocador de Sódio e Cálcio/antagonistas & inibidores , Tiazepinas/farmacologia , Trifluoperazina/metabolismo
10.
Brain Res ; 731(1-2): 21-30, 1996 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-8883850

RESUMO

Single neurons in culture express a heterogeneity of neurotransmitter receptor subtypes. The study of the effects of neurotransmitters on neuronal function is complicated by this heterogeneity. It would therefore be useful to be able to identify live neurons that express the receptors of interest and then use these neurons for functional studies. We have used quantitative fluorescence microscopy to identify single live striatal neurons that express D1 dopamine receptors. The binding of the fluorescent D1 dopamine receptor antagonist bodipy-SCH 23390 was measured in 2-3-week-old primary striatal cultures derived from fetal rats (embryonic day 18). Binding of bodipy-SCH 23390 to live neurons was displaced by (+)-butaclamol, dopamine or SCH 23390, indicating that it specifically labelled D1 dopamine receptors. However, the fraction of bodipy-SCH 23390 binding that was specific varied substantially among individual neurons indicating heterogeneity of D1 dopamine receptor expression. Interestingly, bodipy-SCH 23390 also specifically labelled discrete spots of receptors on the neuronal processes. This technique should prove useful in the study of the effects of dopaminergic drugs on neuronal function in primary culture.


Assuntos
Neostriado/citologia , Neurônios/química , Receptores de Dopamina D1/análise , Ácidos/análise , Animais , Benzazepinas/metabolismo , Ligação Competitiva/fisiologia , Compostos de Boro , Compartimento Celular/fisiologia , Células Cultivadas/química , Antagonistas de Dopamina/farmacologia , Corantes Fluorescentes , Cinética , Microscopia de Fluorescência , Mitocôndrias/química , Mitocôndrias/metabolismo , Neuritos/química , Neurônios/citologia , Neurônios/ultraestrutura , Ratos , Receptores de Dopamina D1/antagonistas & inibidores , Receptores de Dopamina D1/metabolismo
11.
J Neurochem ; 64(5): 2049-56, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7536804

RESUMO

We investigated the modulation of (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)-induced increases in intracellular free Ca2+ ([Ca2+]i) and intracellular free Mg2+ ([Mg2+]i) by cyclothiazide and GYKI 52466 using microspectrofluorimetry in single cultured rat brain neurons. AMPA-induced changes in [Ca2+]i were increased by 0.3-100 microM cyclothiazide, with an EC50 value of 2.40 microM and a maximum potentiation of 428% of control values. [Ca2+]i responses to glutamate in the presence of N-methyl-D-aspartate (NMDA) receptor antagonists were also potentiated by 10 microM cyclothiazide. The response to NMDA was not affected, demonstrating specificity of cyclothiazide for non-NMDA receptors. Almost all neurons responded with an increase in [Ca2+]i to both kainate and AMPA in the absence of extracellular Na+, and these Na(+)-free responses were also potentiated by cyclothiazide. GYKI 52466 inhibited responses to AMPA with an IC50 value of 12.0 microM. Ten micromolar cyclothiazide significantly decreased the potency of GYKI 52466. However, the magnitude of this decrease in potency was not consistent with a competitive interaction between the two ligands. Cyclothiazide also potentiated AMPA- and glutamate-induced increases in [Mg2+]i. These results are consistent with the ability of cyclothiazide to decrease desensitization of non-NMDA glutamate receptors and may provide the basis for the increase in non-NMDA receptor-mediated excitotoxicity produced by cyclothiazide.


Assuntos
Ansiolíticos , Benzotiadiazinas/farmacologia , Cálcio/metabolismo , Magnésio/metabolismo , Neurônios/metabolismo , Prosencéfalo/citologia , Receptores de AMPA/fisiologia , Animais , Benzodiazepinas/farmacologia , Células Cultivadas , Sinergismo Farmacológico , Ácido Glutâmico/farmacologia , Ácido Caínico/farmacologia , Neurônios/efeitos dos fármacos , Prosencéfalo/embriologia , Ratos , Receptores de AMPA/antagonistas & inibidores , Receptores de AMPA/efeitos dos fármacos , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiônico/farmacologia
12.
Brain Res ; 592(1-2): 310-6, 1992 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-1450920

RESUMO

We studied the effects of nitric oxide (NO) and the NO-releasing agents sodium nitroprusside (SNP), S-nitroso-N-acetylpenicillamine (SNAP) and isosorbide dinitrate (ISDN) on N-methyl-D-aspartate (NMDA)-induced increases in intracellular Ca2+ ([Ca2+]i), whole-cell patch-clamp currents and on glutamate-stimulated [3H]dizocilpine binding. NO and agents that release NO partially inhibit increases in [Ca2+]i at concentrations between 1 microM and 1 mM. These agents also decrease [Ca2+]i changes produced by kainate and potassium, but to a smaller extent. As the effects of NO are still present following alkylation of the redox modulatory site on the NMDA receptor this action of NO is probably not a consequence of oxidation of the redox site. In contrast to SNP, ISDN does not inhibit NMDA-induced whole cell patch-clamp currents suggesting that NO modulates [Ca2+]i via perturbation of a Ca2+ homeostatic process. Furthermore, SNP may have a direct action on the NMDA receptor complex in addition to the generation of NO. 8-Bromo-cGMP does not mimic the inhibitory effect of NO suggesting that this effect is not the result of NO stimulation of neuronal cGMP production. As the production of NO in neurons is dependent on increases in [Ca2+]i associated with NMDA receptor activation, these data suggest that NO-mediated decreases in [Ca2+]i may represent a novel feedback inhibitory mechanism for NO production in the brain.


Assuntos
Cálcio/metabolismo , Membranas Intracelulares/metabolismo , N-Metilaspartato/farmacologia , Neurônios/metabolismo , Óxido Nítrico/farmacologia , Prosencéfalo/metabolismo , Animais , Encéfalo/metabolismo , Células Cultivadas , Maleato de Dizocilpina/antagonistas & inibidores , Maleato de Dizocilpina/metabolismo , Dinitrato de Isossorbida/farmacologia , Nitroprussiato/farmacologia , Oxirredução , Penicilamina/análogos & derivados , Penicilamina/farmacologia , Prosencéfalo/citologia , Ratos , Receptores de N-Metil-D-Aspartato/metabolismo , S-Nitroso-N-Acetilpenicilamina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...